Pandemic Diary: Merah Putih Vaccine Lags (Way) Behind

Merah Putih vaccine developed by an Indonesian biomedicine company, Biofarma, is still in progress.

And March 2020 will see the distribution of the vaccine to the industry and continue to a series of clinical tests.

In other words, there is still a long way to go.

The vaccine is reaching 60% of completion of its lab process, says Indonesian official.

But Indonesians are too tired and bored to wait for this sluggish progress.

In the end of 2020, we break boundaries and go wild.

It’s Christmas and New Year holiday anyway, and everyone feels entitled to enjoying some moments of unwinding after overworking and being tied at home like prisoners.

Author: akhlis

Writer & yogi

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: